Supplemental
. Quantitative PCR cycling curves for 18S and KCNJ5 in brain versus KO tissues. In the wild-type tissue the cycling threshold (Ct) was ~24 for KCNJ5. There was no detectable KCNJ5 signal in the KO tissues even after 40 cycles. Figure S3 . Sashimi plot of RNAseq data for KCNJ5 gene locus to show expression level and splicing events in WT and KCNJ5 ( -/-) KO mouse adrenal RNA. There are no RNAseq sequences in the KO adrenal that map to exon 3 of KCNJ5.

Supplemental figure S4.
Curve showing relative viability of H295 cells cultured for 72 hrs with PPAR agonists (Rosi, rosiglitazone; Feno, fenofibrate) . Data is mean ± SEM for n=3.
Supplemental figure S5. Dose response curves for rosiglitazone and fenofibrate. Aldosterone measurements were made after 48 hours exposure of H295 cells to either drug in the presence and absence of Ang II (10nM). Data is mean ± SEM for n=3.
Supplemental figure S5.
Schema to explain the observed aldosterone production in the KO mouse. A. (A). AngII activation of its GPCR receptor depolarizes ZG cells by closing TASK K channels. The G βγ subunits generated by the AngII GPCR will also open KCNJ5 (GIRK4) channels. This can repolarize the ZG cell switching off aldosterone synthesis triggered by depolarization (B). This suggests KO of the channel may increase not decrease aldosterone production (B and C). However, KO of KCNJ5 in the ZG does not occur in isolation as the RNAseq data shows. The IPA predicts reduced PPARA/G signalling in the KO adrenal, which reduces aldosterone synthesis directly antagonising the impact of loss of the KCNJ5 channel itself (D). 
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